Journal profile · Immunology
Journal of Leukocyte Biology
ISSN 0741-5400 · eISSN 1938-3673 · John Wiley & Sons Inc. · UNITED STATES · Monthly
Journal of Leukocyte Biology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.35; hybrid open access; APC about USD 3,800; median 139 days to acceptance (100 articles, last 24 months); community-reported acceptance: about 50%; 191 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Leukocyte Biology is published by John Wiley & Sons Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Immune Response and Inflammation, Immune Cell Function and Interaction and T-cell and B-cell Immunology, together about 39.3% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
JLB is an international, peer-reviewed, academic journal published by the Society for Leukocyte Biology (SLB) and Oxford University Press (OUP) for SLB members and the world-wide community of immunobiologists. The journal publishes papers devoted to the exploration of the cellular and molecular biology of all types of leukocytes including granulocytes, mononuclear phagocytes, lymphocytes, NK cells, and other cells involved in host defense. Since basically all cells in the body can interact with leukocytes, JLB also considers articles involving other cells such as epithelial and endothelial cells, fibroblasts, neurons, and other somatic cell types participating in host defense. Studies covering leukocyte development, differentiation, trafficking and effector functions using different in vitro, in situ and in vivo approaches are of particular interest. JLB also publishes clinical, translational, and interdisciplinary studies exploring leukocyte functions in the pathophysiology of immune responses, inflammatory diseases, and cancer. Analysis of extracellular mediators, effector molecules, receptors, signal transduction and genetics are considered relevant. JLB also publishes bioinformatical, mathematical modeling, and big data approaches aimed at understanding leukocyte functions. Research articles, reports, clinical case studies with a focus on leukocyte biology, and reviews that provide novel mechanistic understanding in any of these fields are given priority. Additionally, articles covering technical advances related to state-of-the-art leukocyte research methods and any type of educational material of interest to the world-wide leukocyte biology community are also considered and/or invited.
From the journal's Aims & Scope
Research area (LetPub): Immunology
Editor-in-chief Michael SchnoorPublisher website
Editorial board by country: 7 in mainland China (about 13%); most named Mainland China 7, Germany 6, Mexico 5, United States 4, United Kingdom 4 (53 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immune Response and InflammationImmunology and Microbiology16.2%
- Immune Cell Function and InteractionImmunology and Microbiology14.5%
- T-cell and B-cell ImmunologyImmunology and Microbiology8.6%
- Immunotherapy and Immune ResponsesImmunology and Microbiology7.7%
- Immune cells in cancerImmunology and Microbiology6.4%
- Neutrophil, Myeloperoxidase and Oxidative MechanismsImmunology and Microbiology6.3%
- Cell Adhesion Molecules ResearchMedicine6%
- Chemokine receptors and signalingMedicine2.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Hematology | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
| Minor | Cell Biology | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCASCAB AbstractsCurrent ContentsPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.35LetPub ·
- Impact factor (publisher) 2025
- 4.7Publisher website ·
- 5-year impact factor (publisher) 2025
- 34Publisher website ·
- CiteScore 2026-06
- 6.1LetPub ·
- CiteScore (publisher) 2025
- 84Publisher website ·
- SJR 2026-06
- 1.2LetPub ·
- SNIP 2026-06
- 0.74LetPub ·
- h-index
- 175LetPub ·
- h-index
- 264OpenAlex ·
- i10-index
- 7,557OpenAlex ·
- 2-year mean citedness
- 3.83OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 30.64%LetPub ·
Volume
- Articles per year
- 160LetPub ·
- Downloads per year (publisher) 2025
- 551,025Publisher website ·
Articles by year OpenAlex count · 10,980 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 128 | 78 | 48 |
| 2025 | 191 | 99 | 488 |
| 2024 | 264 | 149 | 1,697 |
| 2023 | 182 | 133 | 1,905 |
| 2022 | 171 | 85 | 2,243 |
| 2021 | 208 | 91 | 4,640 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
139 daysMedian, submission to acceptance · P25–P75 96 days – 183 days
- Acceptance to online
- median 12 days (13 articles)
- Submission to online
- median 137 days
- Sample
- 100 articles with submission and acceptance dates (462 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
- Submission to first decision
- 23 daysPublisher website ·
- Submission to first decision 2025
- 28 daysPublisher website ·
- Submission to final decision 2025
- 37 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,800 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Latest open access paper
Diminished FcγRIIa expression reduces antibody-mediated phagocytosis by low-density neutrophils in obesity Carlos Blanco-Camarillo and others Journal of Leukocyte Biology, qiag128, https://doi.org/10.1093/jleuko/qiag128 Published: 15 September 2026 Obesity reduces phagocytosis by low-density neutrophils
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- John Wiley & Sons Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- ISSN
- 0741-5400
- Electronic ISSN
- 1938-3673
- Latest issue on the website
- Volume 118, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Leukocyte Biology
What CAS zone is Journal of Leukocyte Biology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Leukocyte Biology is in Zone 4 of Medicine, and in Zone 4 of the minor category Cell Biology / Hematology / Immunology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Leukocyte Biology?
The latest impact factor listed by LetPub is 3.35; CiteScore 6.1, h-index 264.
How long does peer review take at Journal of Leukocyte Biology?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 139 days (interquartile range 96–183 days); authors report an average review time of about 2 months; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Leukocyte Biology based?
Of the 53 board members whose country the journal's board page names, 7 (about 13%) are in mainland China; the countries named most often are Mainland China (7), Germany (6) and Mexico (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Leukocyte Biology?
According to LetPub and DOAJ records, Journal of Leukocyte Biology is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Journal of Leukocyte Biology open access, and what is the APC?
Journal of Leukocyte Biology is a hybrid journal. For open-access publication: APC about USD 3,800.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .